Supreme Drugs Private Limited - Company Profile

It is a pharma private limited company based in Banaskatha, Gujarat, India, established in 2021.
2021 Banaskatha, Gujarat, India Active
Last Updated:
Access Report
About Supreme Drugs Private Limited

Supreme Drugs Private Limited, a active private limited company, was established on 27 August 2021 in Banaskatha, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24290GJ2021PTC125153. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Jayantilal Maganlal Patel (Director), Ashokkumar Hiralal Patel (Director), Dineshkumar Ramabhai Panchasara (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shree Tirupati Ind, Ta-Palanpur, Village Dist- Banaskatha,, Banaskatha, Gujarat, 385001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290GJ2021PTC125153

  • Registration Number

    125153

  • Incorporation Date

    27 August 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 4 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 2528.73%
  • Profit Growth **** 35.77%
  • Ebitda **** 38.65%
  • Net Worth -60.52%
  • Total Assets -4.62%
Company report

Supreme Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Supreme Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Supreme Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Jayantilal Maganlal Patel Director 01 Nov 2023 Current
Ashokkumar Hiralal Patel Director 27 Aug 2021 Current
Dineshkumar Ramabhai Panchasara Director 27 Aug 2021 Current
Keshav Deo Director 17 Feb 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Supreme Drugs.

Supreme Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2528.73% increase. The company also saw a substantial improvement in profitability, with a 35.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 60.52%.

Supreme Drugs revenue growth over time
Supreme Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 2528.73%
*******
*******
*******
*******
Revenue from Operations
*******
 2552.97%
*******
*******
*******
*******
Total Assets
*******
 -4.62%
*******
*******
*******
*******
Profit or Loss
*******
 35.77%
*******
*******
*******
*******
Net Worth
*******
 -60.52%
*******
*******
*******
*******
EBITDA
*******
 38.65%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Supreme Drugs?

Unlock access to Supreme Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Supreme Drugs?

Supreme Drugs has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Supreme Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supreme Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Supreme Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Supreme Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Supreme Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Director Appointment

    The activity Jayantilal Maganlal Patel was appointed as a Director was appointed as a Director on 01 Nov 2023 & has been associated with this company since 2 years 4 months . was completed.

  • Director Appointment

    Progress on Keshav Deo was appointed as a Director was appointed as a Director on 17 Feb 2022 & has been associated with this company since 4 years 16 days . was documented.

  • Director Appointment

    Progress on Ashokkumar Hiralal Patel was appointed as a Director was appointed as a Director on 27 Aug 2021 & has been associated with this company since 4 years 6 months . was documented.

  • Director Appointment

    Progress on Dineshkumar Ramabhai Panchasara was appointed as a Director was appointed as a Director on 27 Aug 2021 & has been associated with this company since 4 years 6 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Supreme Drugs Private Limited?

The CIN of Supreme Drugs Private Limited is U24290GJ2021PTC125153.

Where is Supreme Drugs Private Limited headquartered?

Supreme Drugs Private Limited is headquartered at Shree Tirupati Ind, Ta-Palanpur, Village Dist- Banaskatha,, Banaskatha, Gujarat, 385001.

When was Supreme Drugs Private Limited incorporated?

Supreme Drugs Private Limited was incorporated on 27 August 2021.

Who are the current directors of Supreme Drugs Private Limited?

The current directors of Supreme Drugs Private Limited are

What is the primary industry of Supreme Drugs Private Limited?

The primary industry of Supreme Drugs Private Limited is Manufacturing.

Is Supreme Drugs Private Limited a listed company?

Supreme Drugs Private Limited is unlisted.

What is the capital structure of Supreme Drugs Private Limited?

The authorized capital of Supreme Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Supreme Drugs Private Limited?

The compliance status of Supreme Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available